SEC Form 4 · accession 0001209191-18-001544
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry M Smith
Officer — Chief Executive Officer · Director
Period of report
Jan 2, 2018
Accepted (ET)
Jan 3, 2018 · 7:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Jan 2, 2018 | X | 13,367 | $51.79 | A | 42,799 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Jan 2, 2018 | S | 13,367 | $95.9399 | D | 29,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F4,F3 | $51.79 | Jan 2, 2018 | X | 13,367 | D | — | Feb 1, 2023 | Common Stock | 13,367 | 307,625 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $95.05 to $97.0250, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3All of the stock options in this tranche have vested in full.
- F4Not applicable.